A detailed history of Btg Pactual Asset Management Us LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Btg Pactual Asset Management Us LLC holds 20,000 shares of CTLT stock, worth $1.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$1.27 Million
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.16 - $60.96 $1.12 Million - $1.22 Million
20,000 New
20,000 $1.21 Billion

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Btg Pactual Asset Management Us LLC Portfolio

Follow Btg Pactual Asset Management Us LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Asset Management Us LLC, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Asset Management Us LLC with notifications on news.